Exagen announces acceptance of five abstracts at 2024 american college of rheumatology convergence

Carlsbad, calif., oct. 21, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing, announced today the acceptance of five abstracts at the 2024 american college of rheumatology's (acr) annual meeting, acr convergence 2024, being held november 14-19, 2024, at the walter e. washington convention center in washington, d.c.
XGN Ratings Summary
XGN Quant Ranking